Programme
Wednesday 17 November 2021
Central European Time
(CET)

UK time
(GMT)
 
15.00 - 15.10 14.00 - 14.10 Workshop introduction
15.10 - 15.40 14.10 - 14.40 Introduction to Darter initiative
Virginia Arechavala-Gomeza, Osakidetza, Spain
15.40 - 16.10 14.40 - 15.10 ADME strategy
Ben-Filippo Krippendorff, Roche, Switzerland
16.10 - 16.40 15.10 - 15.40 Introduction to NATA initiative
Martin Kerr, Research Complex at Harwell (RCaH), UK
16.40 - 17.00 15.40 - 16.00 Break
17.00 - 17.30 16.00 - 16.30 Oligo QWBA hot or not?
David Kenworthy, GSK, UK
17.30 - 18.00 16.30 - 17.00 Multimodal Imaging of Therapeutic Oligos
Prabuddha Mukherjee & Aneesh Alex, UIUC, USA
18.00 - 18.30 17.00 - 17.30 Discussion
 
Thursday 18 November 2021
Central European Time
(CET)

UK time
(GMT)
 
15.00 - 15.10 14.00 - 14.10 Workshop introduction
15.10 - 15.40 14.10 - 14.40 Introduction to OligoNova initiative
Shalini Andersson, AZ, Sweden
15.40 - 16.10 14.40 - 15.10 Update on the OSWG PK/ADME Subcommittee's Recommendations
Cindy Berman, Independent Consultant, US
16.10 - 16.40 15.10 - 15.40 DMPK/ADME considerations of oligonucleotides in Discovery and Development
Rasmus Jansson-Löfmark, AZ, Sweden
16.40 - 17.00 15.40 - 16.00 Break
17.00 - 17.30 16.00 - 16.30 Incoming Qs/hot topics
Steve Hood, GSK, UK
17.30 - 18.00 16.30 - 17.00 Discussion